Hensoldt (OTCMKTS:HAGHY – Get Free Report) was upgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong-buy” rating in a report released on Tuesday,Zacks.com reports.
Other equities analysts have also recently issued reports about the company. Barclays upgraded Hensoldt to a “hold” rating in a report on Monday, September 8th. Citigroup raised shares of Hensoldt from a “hold” rating to a “buy” rating in a research note on Friday, November 14th. Cantor Fitzgerald upgraded shares of Hensoldt to a “strong-buy” rating in a report on Friday, November 7th. Finally, DZ Bank upgraded shares of Hensoldt to a “strong-buy” rating in a report on Friday, October 31st. Three equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Hensoldt has a consensus rating of “Moderate Buy”.
Check Out Our Latest Analysis on Hensoldt
Hensoldt Trading Up 5.9%
About Hensoldt
Hensoldt AG (OTCMKTS: HAGHY) is a Germany-based defense and security electronics company specializing in sensor solutions for military and civilian applications. Formed in 2017 through the spin-off of Airbus Defence and Space’s electronics division, Hensoldt has established itself as a leading provider of radar, optronics, electronic warfare systems, and command-and-control solutions. The company’s product portfolio spans airborne and naval radar systems, electro-optical and infrared (EO/IR) reconnaissance payloads, self-protection suites for aircraft and land vehicles, as well as integrated mission systems for surveillance and reconnaissance platforms.
Headquartered in Taufkirchen, near Munich, Hensoldt serves a global customer base that includes armed forces, governmental agencies, and critical infrastructure operators across Europe, the Americas, Asia-Pacific, and the Middle East.
Further Reading
- Five stocks we like better than Hensoldt
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Do not delete, read immediately
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Hensoldt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hensoldt and related companies with MarketBeat.com's FREE daily email newsletter.
